3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other neoplasm
1
Gastrointestinal
1
Conditions
Rectal Neoplasms
1
Prostatic Neoplasms
1
Precancerous Conditions
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Adenomatous Polyps
1
Interventions
Fluorouracil
20
Leucovorin
18
Oxaliplatin
11
Irinotecan
10
Capecitabine
6
Bevacizumab
5
Cetuximab
4
Levamisole
3
Celecoxib
3
cediranib
2
Watchful Waiting
2
Tegafur
2
Surveys and Questionnaires
2
Psychiatric Rehabilitation
2
Folfox protocol
2
Counseling
2
Cisplatin
2
tumor necrosis factor-alpha, CNGRC fusion protein, human
1
tipifarnib
1
regorafenib
1
pertuzumab
1
olaparib
1
mercaptoundecahydrododecaborate
1
gevokizumab
1
eniluracil
1
cemiplimab
1
brivanib
1
alpha-Tocopherol
1
Vitamin E
1
Uracil
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NETWORK
×
Colonic Neoplasms
×
alpha-Tocopherol
×
Clear all
NCT00706121
2019-12-16
ACP
SWOG Cancer Research Network
Phase 3
Completed
8,094 enrolled
23 charts